Burns & Levinson represented BTR (Boston Technology Research Corporation) on the matter. BTR (Boston Technology Research Corporation), a regulatory technology company serving healthcare, life sciences and SaMD,...
BTR’s $15 Million Series A Preferred Financing Raise
AcelRx Pharmaceuticals’ $32.5 Million Acquisition of Lowell Therapeutics
Burns & Levinson LLP represented Lowell Therapeutics, Inc. in its sale to AcelRx Pharmaceuticals. AcelRx Pharmaceuticals (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and...